- Issuer
- Fidelity
- Inception Date
- Apr 16, 2020
- Category
- Health & Biotech Equities
- Leveraged
- 1x (No leverage)
- Index Tracked
- No Index (Active)
- Distribution Policy
- Accumulating
- Asset Class
- Equity
- Asset Class Size
- Mid-Cap
- Asset Class Style
- Growth
- Assets Under Management
- $41M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
FMED Performance Chart
Fidelity Disruptive Medicine ETF (FMED) is down 2.4% since the beginning of the year. FMED is currently trading at $26 per share.
Loading charts...
Returns By Period
Fidelity Disruptive Medicine ETF (FMED) has returned -2.44% so far this year and 12.97% over the past 12 months.
Fidelity Disruptive Medicine ETF
- 1D
- 1.03%
- 1M
- 6.62%
- YTD
- -2.44%
- 6M
- -4.06%
- 1Y
- 12.97%
- 3Y*
- 1.97%
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -1.44%
- 1M
- -1.45%
- YTD
- 7.60%
- 6M
- 6.59%
- 1Y
- 22.24%
- 3Y*
- 19.20%
- 5Y*
- 11.54%
- 10Y*
- 13.71%
FMED Monthly Returns History
Based on dividend-adjusted daily data since Jun 12, 2023, FMED's average daily return is +0.01%, while the average monthly return is +0.26%. At this rate, an investment would double in approximately 22.2 years.
Historically, 54% of months were positive and 46% were negative. The best month was Dec 2023 with a return of +12.6%, while the worst month was Oct 2023 at -8.4%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 4 months.
On a daily basis, FMED closed higher 49% of trading days. The best single day was Apr 9, 2025 with a return of +6.6%, while the worst single day was Apr 4, 2025 at -5.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -1.39% | -1.74% | -6.27% | 0.97% | 1.45% | 4.87% | -2.44% | ||||||
| 2025 | 6.69% | -4.34% | -6.19% | 1.33% | -2.23% | 2.38% | -1.16% | 3.53% | 1.79% | 5.10% | 9.98% | -6.19% | 9.69% |
| 2024 | -0.36% | 4.22% | 1.47% | -6.39% | -1.54% | 2.31% | 2.65% | 5.34% | 1.04% | -2.89% | 2.78% | -5.60% | 2.29% |
| 2023 | -0.08% | 1.07% | -5.90% | -7.29% | -8.41% | 6.12% | 12.59% | -3.59% |
Benchmark Metrics
Fidelity Disruptive Medicine ETF has an annualized alpha of -11.47%, beta of 0.83, and R2 of 0.45 versus S&P 500 Index. Calculated based on daily prices since June 12, 2023.
- This ETF participated in 152.37% of S&P 500 Index downside but only 66.57% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.45 means the benchmark explains less than half of this ETF's behavior - treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- -11.47%
- Beta
- 0.83
- R²
- 0.45
- Upside Capture
- 66.57%
- Downside Capture
- 152.37%
Expense Ratio
FMED has an expense ratio of 0.50%, placing it in the medium range.
Return for Risk
Risk / Return Rank
FMED ranks 19 for risk / return — in the bottom 19% of ETFs on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Fidelity Disruptive Medicine ETF (FMED) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FMED | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.11 | ||
| Sortino ratioReturn per unit of downside risk | -1.32 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 1.32 | -0.20 |
| Calmar ratioReturn relative to maximum drawdown | 0.71 | 2.46 | -1.75 |
| Martin ratioReturn relative to average drawdown | 1.55 | 10.92 | -9.37 |
Dividends
Dividend History
Fidelity Disruptive Medicine ETF provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.
| Period | TTM | 2025 | 2024 |
|---|---|---|---|
| Dividend | $0.00 | $0.00 | $0.11 |
Dividend yield | 0.00% | 0.00% | 0.46% |
Monthly Dividends
The table displays the monthly dividend distributions for Fidelity Disruptive Medicine ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.11 | $0.11 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Fidelity Disruptive Medicine ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Fidelity Disruptive Medicine ETF was 21.84%, occurring on Oct 30, 2023. Recovery took 81 trading sessions.
The current Fidelity Disruptive Medicine ETF drawdown is 8.48%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2023 bear market2023 | -21.84%Oct 2023 | 3mo 8d | 4mo | 7mo 8dJul 2023 - Feb 2024 |
2025 selloff2025 | -19.46%Apr 2025 | 2mo 7d | 6mo 22d | 8mo 29dJan 2025 - Oct 2025 |
2026 correction2026 | -18.33%Mar 2026 | 3mo 29d | — | 6mo 25dDec 2025 - now |
2024 pullback2024 | -8.49%Jun 2024 | 3mo 21d | 2mo 4d | 5mo 25dFeb 2024 - Aug 2024 |
2024 pullback2024 | -7.13%Nov 2024 | 1mo 26d | 19d | 2mo 15dSep 2024 - Dec 2024 |
Drawdown Indicators
| FMED | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -21.84% | -56.78% | +34.94% |
Max Drawdown (1Y)Largest decline over 1 year | -18.33% | -9.10% | -9.23% |
Max Drawdown (3Y)Largest decline over 3 years | -21.84% | -18.90% | -2.94% |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -8.48% | -3.21% | -5.27% |
Average DrawdownAverage peak-to-trough decline | -7.11% | -10.71% | +3.60% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.38% | 2.04% | +6.34% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Build a portfolio with FMED
Add Fidelity Disruptive Medicine ETF to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with FMED